D-myo-Inositol 1,3,4,5,6-pentakisphosphate pentapotassium salt reduces the IP4 binding activity of Bruton's tyrosine kinase (Btk).
Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation: L.R. Stephens, et al.; Biochem. J. 253, 721 (1988) Inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate are inhibitors of the soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase and the inositol 1,4,5-trisphosphate/1,3,4,5-tetrakisphosphate 5-phosphatase from pig brai: A. Höer & E. Oberdisse; Biochem. J. 278, 219 (1991) Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity: M. Fukuda, et al.; J. Biol. Chem. 271, 30303 (1996)
See how others have used D-myo-Inositol 1,3,4,5,6-pentakisphosphate pentapotassium salt. Click on the entry to view the PubMed entry .
PMID: # 24649396 Abe, TK. et al. 2014. FEBS Open Bio. 4: 162-7.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.